Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
How can banks conduct due diligence at a time when so few are willing or able to travel? Staff at one Chinese broker have been presented with a rather unappealing solution.
-
Mexico’s deputy finance minister told GlobalCapital that proceeds from Wednesday’s $6bn blow-out bond would not be used to help state oil giant Pemex, despite several investors believing the government needed to issue more to prop up the debt-laden company with oil price having crashed in the wake of the coronavirus pandemic. -
CLO managers are on the defensive as the pace of leveraged loan downgrades accelerates in April.
-
The European Central Bank’s purchase programme will do little to aid agencies in raising cash in the commercial paper market, making little difference to rising borrowing costs and expanding programmes, according to Jérôme Margerin, head of short-term funding at ACOSS, one of Europe’s largest non-sovereign CP issuers.
-
Spain enjoyed enormous demand for a 10 year syndicated bond on Tuesday, with an order book which was almost double the previous record for a single tranche euro public sector benchmark. Bankers away from the deal said investors were attracted by the big new issue premium on offer.
-
Oil trading at minus $40 a barrel may be a one-off, but ultra-cheap oil is not. The industry’s bonds may look attractive at the current inflated yields — but they should tempt only investors who are brave, patient and selective.
